New Products

First continuous OC now available in pharmacies

The FDA based its approval on two 1-year clinical studies of more than 2,400 women. The federal agency has asked Wyeth to conduct a postmarketing study of serious adverse events to assess whether long-term effects differ from those seen with other OCs. For more information, visit. http://www.lybrel.com/.

A new anatomically shaped product for anterior and posterior pelvic floor repair has been introduced by Cook Women's Health (Spencer, Ind.). The company says its Surgisis Biodesign combines attributes of synthetic mesh and biologic grafts, while addressing special challenges like resistance to infection, encapsulation, and erosion. The product is said to communicate with a patient's body, signaling surrounding cells to grow across the scaffold, allowing the body to restore itself naturally, resulting in remodeled tissue that's strong and flexible. Cook says that Surgisis Biodesign is undetectable after the body heals, providing a permanent repair. For more information, visit http://www.cookmedical.com/.

Device aims to curb trocar insertion injuries

Available in 5 and 10/11-mm sizes, the easy-to-use device fits any style trocar and can be attached and sutured into place in seconds. For more information, visit http://www.innovamed-us.com/.